Navigation Links
EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
Date:6/27/2012

BOSTON, June 27, 2012 /PRNewswire/ --

EvaluatePharma®, the premier source for pharmaceutical and biotechnology sector analysis and consensus forecasts, has named Debbie Paul to the position of CEO Americas, EvaluatePharma USA, Inc. effective immediately.  In her new role, Paul leads EvaluatePharma's growing North American operations and its strategic expansion into Canada and Latin America.

Debbie Paul has been a key member of the EvaluatePharma executive team since 2004, most recently serving as Senior Vice President, North America.  She brings knowledge gained through more than 25 years of truly diverse healthcare and life science industry experience, ranging from being a critical-care nurse manager to directing market research for a global pharmaceutical company.  

Jonathan de Pass remains as chief executive of the U.K.-based parent company, EvaluatePharma Ltd. Dr. de Pass founded EvaluatePharma in 1996, leading the way in creating new industry standards for consensus forecasting global drug sales and other performance metrics for the pharmaceutical and biotech sectors, as exemplified in two recent industry reports: "World Preview 2018: Embracing the Patent Cliff" and "Surveying Tomorrow's Biopharma Landscape: The NASDAQ Biotech Index Up Close." Dr. de Pass has since expanded EvaluatePharma into the United States and Japan markets, serving a growing demand for the company's data analysis.

"Debbie has clearly demonstrated her strategic leadership in growing and serving EvaluatePharma's expanding client base in the Americas," said Dr. de Pass.  "Her experience and comprehensive understanding of the pharmaceutical and biotechnology marketplace, as well as the healthcare industry at large, gives her a talent for delivering actionable knowledge to all of the sector's participants, big and small.  She stands out as the leader with the expertise to continue our growth during such a pivotal time for pharmaceutical and biotechnology industries in the Americas."  

Prior to joining EvaluatePharma, Debbie Paul served as Director of Market Research at Sandoz, the generics division of global pharmaceuticals company Novartis AG, where her focus was strategic and product planning.  She also worked in the pharmaceutical and medical products practice of management consultancy McKinsey & Co., Inc.  Paul received her Masters of Business Administration from Rice University in Houston, Texas, following a 17-year career as a critical care nurse. She also holds a Bachelor of Science in Nursing from State University of New York in Albany.

About EvaluatePharma

Since 1996, EvaluatePharma has been the premier source for pharmaceutical and biotechnology sector analysis, delivering exclusive, trusted commercial insight into industry performance through its proprietary platform. EvaluatePharma is staffed by a team of 75 dedicated healthcare analysts employing rigorous methodologies to collate, organize and deliver the most-up-to-date commercial performance data available. An award winning editorial team of journalists writing under the EP Vantage name support EvaluatePharma's analysis.  The EvaluatePharma® services enable the life science community to make sound business decisions about value and opportunity. For the complimentary industry reports mentioned above and more information please visit http://www.evaluatepharma.com.

###

Media Contacts:

EvaluatePharma
Christine Lindgren
+1-617-866-3906
christinel@evaluatepharma.com

Chempetitive Group
Erik Clausen
+1-781-608-7091
eclausen@chempetitive.com



'/>"/>
SOURCE EvaluatePharma USA, Inc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DiversityInc Names Lilly a Top Company for Diversity
2. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
3. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
4. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
5. Bausch + Lomb Names John Barr Global President Surgical
6. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
7. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
8. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
9. DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award
10. Cochlear Americas Receives FDA Approval of the Worlds Thinnest, Full Length Electrode for Cochlear Implantation
11. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, ein Weltführer ... bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific Corporation ... agreement to acquire certain manufacturing assets and capabilities of ... NVC) advanced biological tissue business, as well as a ... $75 million in cash. The Neovasc advanced biological tissue ... the Boston Scientific Lotus™ Valve System. * Upon ...
(Date:12/2/2016)... 2016 Lianluo Smart Limited (Nasdaq: ... which develops, markets and sells medical devices and ... and international markets, recently attended the ... New Progress Forum, co-hosted by the Institute of ... , Guangdong Provincial People,s Hospital and Cardiology Department ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders ... American Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in ... , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF Dothan-Wiregrass ... will help provide scholarship funds for area students and operating support to UNCF-member ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame ... (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking ... prescription drug plan (Part D) need to make changes during this period order for ...
Breaking Medicine News(10 mins):